Peer-Reviewed Report on Moderna COVID-19 Vaccine Publishes
Data from phase 3 clinical trial confirm vaccine is effective, and investigators identified no safety concerns
Articles by National Institute of Allergy and Infectious Diseases
NIAID Establishes Centers for Research in Emerging Infectious Diseases
Global network to focus on spillover potential
Phase 3 Clinical Trial of Possible COVID-19 Vaccine Begins
Multi-site trial to test candidate developed by Moderna and NIH
New Coronavirus Stable for Hours on Surfaces
Study results provide key information about the stability of SARS-CoV-2, which causes COVID-19 disease
Investigational Drugs Reduce Risk of Death from Ebola Virus Disease
Study leaders publish results from NIH-DRC-WHO clinical trial of four experimental therapies
Few People with Peanut Allergy Tolerate Peanut after Stopping Oral Immunotherapy
Continuing with a modest dose confers more protection, NIH-funded study finds
HIV/AIDS Research Yields Dividends Across Medical Fields
Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer, and other diseases
During HIV Infection, Antibody Can Block B Cells from Fighting Pathogens
NIH scientists suspect process aims to curb immune-system hyperactivity
Obesity Extends Duration of Influenza a Virus Shedding
NIAID-funded study examines shedding in 320 households during three flu seasons
Tickborne Diseases Are Likely to Increase, Say NIAID Officials
The incidence of tickborne infections in the United States has risen significantly within the past decade